RET oncogene activation in papillary thyroid carcinoma

Advances in Anatomic Pathology

Volumn 8, Issue 6, 2001, Pages 345-354

  Tallini, Giovanni ^a   Asa, Sylvia L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Papillary thyroid carcinoma; RET proto oncogene; RET rearrangements; RET PTC; Thyroid

Indexed keywords

DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA;

GENE REARRANGEMENT; GENETICS; HUMAN; METABOLISM; PAPILLARY CARCINOMA; PATHOLOGY; REVIEW; THYROID TUMOR;

CARCINOMA, PAPILLARY; DROSOPHILA PROTEINS; GENE REARRANGEMENT; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0035516099     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200111000-00005     Document Type: Review

References (95)

1. Airaksinen MS, Titievsky A, Saarma M. GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 1999;13:313-25. (Pubitemid 29256872)
2. Schneider R. The human proto-oncogene ret: a communicative cadherin? Trends Biochem Sci 1992;17:468-9.
3. Tahira T, Ishizaka Y, Itoh F, et al. Characterization of ret proto-oncogene mRNA encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 1990;5:97-102. (Pubitemid 20044809)
4. Santoro M, Rosati R, Grieco M, et al. The RET proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 1990;5:1595-8.
5. Pachnis V, Mankoo B, Costantini F. Expression of the c-RET proto-oncogene during mouse embryogenesis. Development 1993;119:1005-17. (Pubitemid 23358572)
6. Schuchardt A, D'Agati V, Larsson-Blomberg L, et al. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994;367:380-3.
7. Romeo G, Ronchetto P, Luo Y, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994;367:377-8.
8. Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol 1999;17:380-93. (Pubitemid 29022417)
9. Fusco A, Grieco M, Santoro M, et al. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 1987;328:170-2. (Pubitemid 17108219)
10. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990;60:557-63.
11. Bongarzone I, Monzini N, Borrello MG, et al. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine-kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 1993;13:358-66. (Pubitemid 23006913)
12. Santoro M, Dathan NA, Berlingieri MT, et al. Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994;9:509-16. (Pubitemid 24041530)
13. Bongarzone I, Butti MG, Coronelli S, et al. Frequent activation of ret proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 1994;54:2979-85. (Pubitemid 24187783)
14. Klugbauer S, Demidchik EP, Lengfelder E, et al. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary carcinomas of children after Chernobyl. Oncogene 1998;16:671-5. (Pubitemid 28062348)
15. Fugazzola L, Pierotti MA, Vigano E, et al. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a postChernobyl papillary thyroid cancer. Oncogene 1996;13:1093-7. (Pubitemid 26329096)
16. Klugbauer S, Demidchik EP, Lengfelder E, et al. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Res 1998;58:198-203. (Pubitemid 28047053)
17. Klugbauer S, Rabes HM. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999;18:4388-93. (Pubitemid 29392380)
18. Salassidis K, Bruch J, Zitzelsberger H, et al. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in ra-diation-induced childhood papillary thyroid carcinoma. Cancer Res 2000;60:2786-9. (Pubitemid 30395792)
19. Nakata T, Kitamura Y, Shimizu K, et al. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. Genes Chromosomes Cancer 1999;25:97-103. (Pubitemid 29226591)
20. Klugbauer S, Jauch A, Lengfelder E, et al. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8). Cancer Res 2000;60:7028-32. (Pubitemid 32059180)
21. Corvi R, Berger N, Balczon R, et al. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene 2000;19:4236-42.
22. Giannini R, Salvatore G, Monaco C, et al. Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis. Int J Oncol 2000;16:485-9.
23. Elisei R, Romei C, Soldatenko P, et al. New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post Chernobyl papillary thyroid carcinoma. Clin Endocrinol 2000;53:131-6. (Pubitemid 30646136)
24. Santoro M, Carlomagno F, Hay ID, et al. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype. J Clin Invest 1992;89:1517-1522.
25. Santoro M, Sabino N, Ishizaka Y, et al. Involvement of RET oncogene in human tumors: specificity of RET activation to thyroid tumors. Br J Cancer 1993;68:460-4. (Pubitemid 23258446)
26. Bounacer A, Wicker R, Baillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997;15:1263-73. (Pubitemid 27429741)
27. Kroll TG, Sarraf P, Pecciarini L, et al. PAX8-PPARγ fusion in human thyroid carcinoma. Science 2000;289:1357-60. (Pubitemid 30656054)
28. Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997;15:2233-2239. (Pubitemid 27493913)
29. Mizuno T, Kyoizumi S, Suzuki T, et al. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis. Oncogene 1997;15:1455-60. (Pubitemid 27437835)
30. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 1995;55:5617-20.
31. Klugbauer S, Lengfelder E, Demidchik EP, et al. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995;11:2459-67. (Pubitemid 26023813)
32. Nikiforov YE, Rowland JM, Bove KE, et al. Distinct pattern of ret oncogene rearrangements in morphologic variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997;57:1690-4. (Pubitemid 27199660)
33. Smida J, Salassidis K, Hieber L, et al. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int J Cancer 1999;80:32-8. (Pubitemid 28559772)
34. Rabes HM, Demidchik EP, Sidorow JD, et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 postChernobyl papillary thyroid carcinomas: biologic, phenotypic, and clinical implications. Clin Cancer Res 2000;6:1093-103. (Pubitemid 30159372)
35. Alipov G, Ito M, Prouglo Y, et al. Ret proto-oncogene rearrangement in thyroid cancer around Semipalatinsk nuclear testing site. Lancet 1999;354:1528-9. (Pubitemid 29502114)
36. Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 2000;290:138-41.
37. Klugbauer SK, Lengfelder E, Demidchik EP, et al. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene 1996;13:1099-102. (Pubitemid 26329097)
38. Cinti R, Yin L, Ilc K, et al. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. Cytogenet Cell Genet 2000;88:56-61. (Pubitemid 30175596)
39. Mayr B, Potter E, Goretzki P, et al. Expression of Ret/PTC1, -2, -3, -Δ3, and -4 in German papillary thyroid carcinoma. Br J Cancer 1998;77:903-6. (Pubitemid 28101777)
40. Pierotti MA, Bongarzone I, Grazia Borrello M, et al. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer 1996;16:1-14. (Pubitemid 26141248)
41. Durick K, Yao VG, Borrello MG, et al. Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/PTC2. J Biol Chem 1995;270:24642-45.
42. Tong Q, Xing S, Jhiang SM. Leucine-zipper-mediated dimerization is essential for PTC1 oncogenic activity. J Biol Chem 1997;272:9043-7. (Pubitemid 27154905)
43. Borrello MG, Pelicci G, Arighi E, et al. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene 1994;9:1661-8. (Pubitemid 24163393)
44. Salvatore D, Barone MV, Salvatore G, et al. Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. J Clin Endocrinol Metab 2000;85:3898-907.
45. Durick K, Gill GN, Taylor SS. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mol Cell Biol 1998;18:2298-308. (Pubitemid 28152677)
46. Borrello MG, Alberti L, Arighi E, et al. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol Cell Biol 1996;16:2151-63. (Pubitemid 26123736)
47. Takahashi M, Buma Y, Iwamoto T, et al. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 1988;3:571-8. (Pubitemid 19003664)
48. Lanzi C, Borrello MG, Bongarzone I, et al. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 1992;7:2189-94.
49. Monaco C, Visconti R, Barone MV, et al. The RFG oligomerization domain mediates kinase activation and relocalization of the RET/PTC3 oncoprotein to the plasma membrane. Oncogene 2001;20:599-608. (Pubitemid 32156184)
50. Pierotti MA, Santoro M, Jenkins RB, et al. Characterization of a chromosome 10q inversion juxtaposing RET and H4 genes and creating the oncogenic sequence PTC. Proc Natl Acad Sci U S A 1992;89:1616-20.
51. Bunone G, Uggeri M, Mondellini P, et al. RET receptor expression in thyroid follicular epithelial cell-derived tumors. Cancer Res 2000;60:2845-9. (Pubitemid 30395804)
52. Fluge Ø, Haugen DRF, Akslen LA et al. Expression and alternative splicing of c-RET RNA in papillary thyroid carcinomas. Oncogene 2001;20:885-92. (Pubitemid 32198183)
53. Gattei V, Degan M, Rossi FM, et al. The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation. Br J Haematol 1999;105:225-40. (Pubitemid 29197166)
54. Sugg SL, Ezzati S, Rosen IB, et al. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 1998;83:4116-22. (Pubitemid 28513605)
55. Kulkarni S, Heath C, Parker S, et al. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res 2000;60:3592-8. (Pubitemid 30482181)
56. Santoro M, Melillo RM, Grieco M, et al. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ 1993;4:77-84.
57. Fischer AH, Bond JA, Taysavang P. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 1998;153:1443-50. (Pubitemid 28509900)
58. Iwamoto T, Takahashi M, Ito M, et al. Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice. Oncogene 1990;5:533-42
59. Namba H, Yamashita S, Pei H, et al. Lack of PTC gene rearrangement in human thyroid tumors. Endocrinol Jpn 1991;38:627-32.
60. Ishizaka Y, Kobayashi S, Ushijima T, et al. Detection of ret/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 1991;6:1667-72. (Pubitemid 21924271)
61. Zou M, Shi Y, Farid NR. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 1994;73:176-80. (Pubitemid 24012740)
62. Motomura T, Nikiforov YE, Namba H, et al. ret Rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 1998;8:485-9. (Pubitemid 28311297)
63. Tallini G, Santoro M, Helie M, et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 1998;4:287-94. (Pubitemid 28122740)
64. Pierotti MA, Vigneri P, Bongarzone I. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas. Rec Res Cancer Res 1998;154:237-47.
65. Sugg SL, Zheng L, Rosen IB, et al. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 1996;81:3360-5. (Pubitemid 26296216)
66. Fabien N, Paulin C, Santoro M, et al. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridization. Br J Cancer 1992;66:1094-8. (Pubitemid 23006149)
67. Lam AKY, Montone KT, Nolan KA, et al. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histologic parameters. Hum Pathol 1998;29:565-8. (Pubitemid 28272709)
68. Chiappetta G, Hui P, Santoro M, et al. RET/PTC oncogene activation and assessment of clonality in thyroid nodules with minimal cytologic evidence of papillary carcinoma. Lab Invest 2001;81:75A.
69. Bongarzone I, Fugazzola L, Vigneri P, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 1996;81:2006-9. (Pubitemid 26152500)
70. Williams GH, Rooney S, Thomas GA, et al. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer 1996;74:585-9. (Pubitemid 26279054)
71. Soares P, Fonseca E, Wynford-Thomas D, et al. Sporadic retrearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol 1998;185:71-8. (Pubitemid 28266719)
72. Bongarzone I, Vigneri P, Mariani L, et al. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathologic features. Clin Cancer Res 1998;4:223-8. (Pubitemid 28062900)
73. Miki H, Kitaichi M, Masuda E, et al. ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma. J Surg Oncol 1999;71:76-82.
74. Viglietto G, Chiappetta G, Fukunaga FH, et al. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 1995;11:1207-10.
75. Santoro M, Chiappetta G, Cerrato A, et al. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 1996;12:1821-6. (Pubitemid 26146307)
76. Jhiang SM, Sagartz JA, Tong Q, et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996;137:375-8. (Pubitemid 26005013)
77. Powell DJ Jr, Russell J, Nibu K, et al. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res 1998;58:5523-8. (Pubitemid 28551140)
78. La Perle KM, Jhiang SM, Capen CC. Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas. Am J Pathol 2000;157:671-7. (Pubitemid 30626925)
79. Fink A, Tomlinson G, Freeman JL, et al. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol 1996;9:816-20. (Pubitemid 26279271)
80. Cheung CC, Ezzat S, Ramyar L, et al. Molecular basis of Hurthle cell papillary thyroid carcinoma. J Clin Endocrinol Metab 2000;85:878-82. (Pubitemid 32273682)
81. Cheung CC, Boerner SL, MacMillan CM, et al. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 2000;24:1622-6.
82. Papotti M, Volante M, Giuliano A, et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 2000;24:1615-21.
83. Sheils OM, O'Leary JJ, Uhlmann V, et al. ret/PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 2000;8:185-9.
84. Wirtschafter A, Schmidt R, Rosen D, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 1997;107:95-100. (Pubitemid 27045201)
85. Rosai J, Carcangiu MLC, DeLellis RA. Atlas of tumor pathology: tumors of the thyroid gland. Armed Forces Institute of Pathology, 1992.
86. Limpens J, de Jong D, van Krieken JH, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6:2271-6. (Pubitemid 21924073)
87. Asa S. How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape. Mod Pathol 2001;14:246-53. (Pubitemid 32246831)
88. Cheung CC, Carydis B, Ezzat S, et al. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 2001;86:2187-90. (Pubitemid 32472938)
89. Tallini G, Ghossein RA, Emanuel J, et al. Detection of thyroglobulin, thyroid peroxidase and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 1998;16:1158-66. (Pubitemid 28108753)
90. Cho JY, Sagartz JE, Capen CC, et al. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene 1999;18:3659-65. (Pubitemid 29322392)
91. Wajjwalku W, Nakamura S, Hasegawa Y, et al. Low frequency of rearrangement of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 1992;83:671-5.
92. Jhiang SM, Caruso DR, Gilmore E, et al. Detection of the PTC/ret oncogene in human thyroid cancers. Oncogene 1992;7:1331-7.
93. Learoyd DL, Messina M, Zedenius J, et al. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas. J Clin Endocrinol Metab 1998;83:3631-5. (Pubitemid 28500901)
94. Lee C-H, Hsu L-S, Chi C-W, et al. High frequency of rearrangement of the RET proto-oncogene (RET/PTC) in Chinese papillary thyroid carcinomas. J Clin Endocrinol Metab 1998;83:1629-32. (Pubitemid 28501034)
95. Sheils OM, O'Leary JJ, Sweeney EC. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR. J Pathol 2000;192:32-6.